Menu
Back to Journals » Journal of Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma
ISSN: 2253-5969
Editor-in-Chief: Dr Ahmed Kaseb
The Journal of Hepatocellular Carcinoma is an international, peer-reviewed, open access journal.
The journal welcomes original research manuscripts, reviews, clinical trial reports, expert opinions and commentaries relating to all aspects of HCC, spanning from basic laboratory research through to clinical and translational research.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (611)
- Volume 11, 2024 (86)
- Volume 10, 2023 (176)
- Volume 9, 2022 (101)
- Volume 8, 2021 (120)
- Volume 7, 2020 (37)
- Volume 6, 2019 (16)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Latest articles:
- 5 records -
The Potential of the lncRNAs ADAMTSL4-AS1, AC067931 and SOCS2-AS1 in Peripheral Blood Mononuclear Cells as Novel Diagnostic Biomarkers for Hepatitis B Virus-Associated Hepatocellular Carcinoma
Guan W, Zhang C, Miao T, Dong C, Li L, Yuan X, Zhao D, Ai R, Zhang X, Sun M, Kang H, Nan Y
Journal of Hepatocellular Carcinoma 2024, 11:1221-1233
Published Date: 27 June 2024
The Influence of Visceral Adiposity on Overall Survival: Exploring “Obesity Paradox” Among Hepatocellular Carcinoma Patients Who Receiving Immunotherapy
Zhou Y, Ouyang J, Yang H, Wang Z, Yang Y, Li Q, Zhao H, Zhou J, Li Q
Journal of Hepatocellular Carcinoma 2024, 11:1193-1206
Published Date: 24 June 2024
Radiomics-Based Prediction of Microvascular Invasion Grade in Nodular Hepatocellular Carcinoma Using Contrast-Enhanced Magnetic Resonance Imaging
Zhang Z, Jia XF, Chen XY, Chen YH, Pan KH
Journal of Hepatocellular Carcinoma 2024, 11:1185-1192
Published Date: 21 June 2024
GDF15: Immunomodulatory Role in Hepatocellular Carcinoma Pathogenesis and Therapeutic Implications
Du YN, Zhao JW
Journal of Hepatocellular Carcinoma 2024, 11:1171-1183
Published Date: 19 June 2024
PD-1 Inhibitors Combined with Tyrosine Kinase Inhibitors with or without Hepatic Artery Infusion Chemotherapy for the First-Line Treatment of HBV-Related Advanced Hepatocellular Carcinoma: A Retrospective Study
Wang D, Zhang Z, Yang L, Zhao L, Liu Z, Lou C
Journal of Hepatocellular Carcinoma 2024, 11:1157-1170
Published Date: 18 June 2024